Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist illustration of a monitor and patient interaction in a dark color scheme.

Aug 13, 2026

New healthcare AI council prioritizes governance beyond go-live

A new council in healthcare is shifting focus from pre-deployment AI governance to ongoing monitoring after deployment, emphasizing the importance of continuous oversight.The Council for Healthcare AI Responsibility and Safety (CHAIRS), co-founded by Waleed Mohsen, aims to address the critical issue of how AI systems perform in real-world patient interactions after they have been implemented. While traditional governance processes ensure AI tools meet certain criteria before deployment, Mohsen h
A vial of engasertib on a table at a clinical trial site

Aug 13, 2026

Which biotechs have raised new VC financing this week?

This week’s venture capital landscape in biotech showcases significant funding rounds, with Vaderis Therapeutics leading the pack with $152 million aimed at advancing its rare vascular disorder treatment.Vaderis Therapeutics, based in Switzerland, has secured a substantial $152 million in its second financing round, primarily to support the HEROIC phase 3 trial of engasertib, an AKT inhibitor targeting hereditary hemorrhagic telangiectasia (HHT). This rare condition currently lacks FDA-approved
A minimalist illustration of a brain with a pill, symbolizing Parkinson's treatment.

Aug 13, 2026

Remepy raises US $36 million to advance Parkinson's treatment into Phase III

Remepy has successfully secured $36 million in funding to propel its Parkinson's treatment into Phase III clinical trials, marking a significant step in its innovative approach of integrating pharmaceuticals with therapeutic software.This Series A funding round, co-led by Merck KGaA’s M Ventures and O.G. Venture Partners, elevates the startup's total funding to $62 million. The investment roster includes both existing and new stakeholders such as NFX, Vine Ventures, and PsyMed Ventures, among ot
A glucose meter and blood sample in a clinical setting

Aug 13, 2026

Outcomes-Based Digital Health

Outcomes-based digital health is reshaping chronic care management by integrating real-time data with actionable insights.Dexcom has been selected as the first manufacturer for the FDA’s TEMPO pilot, focusing on its Glucose Health Program in conjunction with the CMS ACCESS Model. This initiative aims to leverage real-time metabolic and nutritional data, along with AI-driven guidance, to empower both patients and healthcare providers in making informed decisions. The pilot also emphasizes the col
A minimalist illustration of a pill and circuit symbolizing AI in pharmaceuticals.

Aug 13, 2026

Axtria to Build Industry's Largest Pharma-Specific AI Engineering Team, Scaling to 1,000 by December 2026

Axtria is set to establish the largest AI engineering team dedicated to the pharmaceutical sector, aiming to reach 1,000 engineers by December 2026. This ambitious initiative is a response to the increasing demand for specialized talent capable of deploying AI solutions across various functions in life sciences.Axtria's Forward Deployed Engineering (FDE) model, initiated about a year ago, focuses on the practical application of AI in complex enterprise environments. It emphasizes that success in
A minimalist illustration of a wrist with a watch, representing health tracking.

Aug 13, 2026

Google adds insulin resistance tracker to wearables

Google has launched an innovative insulin resistance tracking feature for its Pixel Watch and Fitbit Air, marking a significant development in consumer health wearables.This new functionality, integrated into the Health Guardian app, utilizes passive sensors on the wrist to monitor various metabolic indicators such as resting heart rate, sleep patterns, skin temperature, and physical activity. While it does not directly measure blood sugar levels or diagnose insulin resistance—which typically re
A DNA sample in a vial on a lab bench with a microscope in the background.

Aug 13, 2026

Human Longevity Launches $600 Whole Genome

Human Longevity has unveiled a new product, Genomics for All, which offers whole genome sequencing at a competitive price of $599, aiming to democratize access to genomic information.This new service provides comprehensive sequencing of an individual's entire genome, covering 6.4 billion base pairs at a clinical-grade depth of 30x. It identifies inherited disease risks linked to over 10,000 genetic variants and highlights pharmacogenomic markers that inform how individuals might respond to medic
minimalist representation of cardiac diagnostics

Aug 13, 2026

Healthway Multi-Specialty Centers digitises cardiac diagnostics across clinics

Healthway Multi-Specialty Centers is enhancing its cardiac diagnostic capabilities through a new partnership with Tricog Health, integrating advanced digital solutions across its clinics in the Philippines.This collaboration introduces Tricog’s AI-driven Insta Electrocardiogram (ECG) and InstaEcho platforms, which will streamline the process of cardiac diagnostics. By uploading ECGs and 2D echocardiograms to a secure cloud platform, cardiologists can conveniently access and analyze test results
Press release cover image

Aug 13, 2026

Press release

FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test

Investigational AI-powered multiomic test is being developed for adults ages 50-80 at high risk who are not currently participating in guideline-recommended lung cancer screeningBRISBANE, Calif., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Freenome, Inc. (Nasdaq: FRNM), an early cancer detection company developing blood-based screening tests, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to SimpleScreen™ Lung, the company’s investigational lu
Illustration of data exchange in healthcare

Aug 12, 2026

Health Gorilla lawsuits consolidated into multidistrict litigation

The recent consolidation of lawsuits against Health Gorilla highlights growing concerns over data governance in healthcare. Multiple cases alleging inadequate vetting and onboarding practices related to the protection of health information are now centralized in the Southern District of Florida, indicating a potential shift in legal scrutiny regarding data sharing among healthcare organizations.The U.S. Judicial Panel on Multidistrict Litigation has combined nine cases, including those from Cali
A clipboard with a patient-reported outcomes form on a wooden desk in a dimly lit healthcare office.

Aug 12, 2026

Strategic Convergence in HealthTech Governance: Analysing Radar Healthcare’s Acquisition of Cemplicity

Radar Healthcare's recent acquisition of Cemplicity signifies a pivotal shift in the HealthTech landscape, aiming to unify patient experience with operational governance.On August 12, 2026, Radar Healthcare announced its acquisition of Cemplicity, a platform specializing in patient-reported outcomes and experiences. This move, supported by Marlin Equity Partners, is part of Radar's broader strategy to enhance its offerings in risk and compliance management within healthcare. This acquisition fol
Flat illustration of a tissue sample and biological chip in a lab setting

Aug 12, 2026

Human Biological Datacenter to Launch to Train World Model of Human Biology

Vivodyne has unveiled an expansive human biological datacenter that aims to revolutionize drug discovery by enabling unprecedented large-scale testing of human tissues.The newly launched facility features 12 robotic HIVE laboratories capable of conducting controlled trials on an estimated 3.1 million large human tissues annually, a capacity that significantly exceeds the total of all U.S. clinical trials combined. Central to this innovation is the Series 2 TissueDisk, a biological chip that can